Power Law company profile

Coherus Oncology

Biotech & Life Sciences · Redwood City, United States · Founded 2010 · IPO 2014 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$129M

Market cap · Apr/2026

Revenue

$42M

Latest reported FY

Investors

6 investors on Coherus Oncology's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage

Medpace

Helix Ventures

Series B+ 4 investors entered at this stage

Lilly Ventures

RA Capital Management

Daiichi Sankyo

KKR

Global footprint

Where Coherus Oncology has talent and traffic

Web traffic by country

8.8K monthly visits
across markets

🇺🇸 United States63.6%

🇯🇵 Japan14.8%

🇬🇧 United Kingdom12.5%

🇮🇳 India9.1%

🇮🇹 Italy0%

Top 5 markets shown

Patent intelligence

$40M patent portfolio · 49 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$40M

31.1% of market cap · 50.5× smaller than top peer Ablynx ($2B)

49 active patent families

Where Coherus Oncology innovates Molecular biologyCarcinosisAntiendomysial antibodiesImmunologyAnti antibody

Below peer median on Strategic, Market

Quality vs same-sector peers

Coherus Oncology on the five Patsnap quality dimensions

Coherus Oncology in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Coherus Oncology concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Coherus Oncology and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Coherus Oncology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo